Skip to main content
Home

Breadcrumb

  1. Home
  2. Pharma

Pharma

ELRIG Logo
21 July 2026

ELRIG Appoints Drs Hitesh Sanganee and Marcus Schindler to Scientific Advisory Board

Leadership expansion reinforces ELRIG's commitment to delivering impactful drug discovery initiatives and driving community-wide collaboration ...

https://www.syngensys.com/
22 July 2026

SynGenSys makes key appointments to strengthen senior commercial and scientific teams

· Heads of Commercial, CHO Expression Technologies, Cell and Gene Therapy Expression Technologies, and Bioinformatics and Data Science appointed to support commercial scale-up· Strengthens alignment between customer needs, product development, scientific positioning, and external engage...

Dr Teresa Nunes, Chief Medical Officer of EpilepsyGTx
22 July 2026

EpilepsyGTx appoints Dr Teresa Nunes as Chief Medical Officer

Appointment of senior clinical leader will support progression of lead candidate EPY201 through the clinic  ...

Milner
20 July 2026

Milner Institute convenes science, industry, investors and charity funders for Pitch Day and Symposium

Researchers, entrepreneurs, investors and global pharmaceutical leaders gathered in Cambridge this week as the Milner Therapeutics Institute hosted its annual Pitch Day and 11th annual Therapeutics Symposium. ...

Aerospace
17 July 2026

Guardtech helping Aerospace applications reach for the stars with an unrivalled range of controlled environment solutions

From small segregation pods to large-scale off-site constructed container facilities, East Anglian contamination control specialists Guardtech have all your Aerospace cleanroom bases covered ...

lab testing
30 March 2026

One in four people with diabetes may have symptomatic, previously undiagnosed heart failure: AstraZeneca and the University of Glasgow announce late-breaking TARTAN-HF results at the American College of Cardiology

A simple, GP-friendly, community-based pathway has identified previously undiagnosed, symptomatic heart failure in approximately one in four high risk people with diabetes.The approach used faster access to echocardiography testing, prompted by symptom inquiry and blood tests (NT-proBNP...

lab testing
24 April 2026

AstraZeneca and Northern Ireland Forge New Strategic Partnership Aiming to Transform Healthcare and Boost Innovation

Belfast, UK, April 24, 2026 – AstraZeneca and Northern Ireland Department of Health, the Department for the Economy and the Health Innovation Research Alliance NI (HIRANI) today announced their intent to enter into a first-of-its-kind strategic Memorandum of Understanding (MOU), aimed a...

Image of existing bio-refinery
25 November 2025

Celtic Renewables appoints Allen Associates as it plans new biorefinery in Grangemouth

Tuesday 25 November 2025 – Celtic Renewables is moving forward with plans to build a new industrial-scale green chemical production plant in Grangemouth. It has appointed engineering design consultancy Allen Associates, part of the Forsyths Group of companies, to undertake extensive wor...

logo
15 July 2026

Cambridge Forum announces world-class speaker line-up for AI & Health Conference

Cambridge Forum is delighted to announce a line-up of eminent speakers for its Tech for Good: AI and Health event, taking place on 10th and 11th September at Cambridge Corn Exchange. ...

Novogene Europe Logo
13 July 2026

Novogene Europe launches Untargeted Metabolomics Service at Cambridge Omics Centre

• Strengthens multiomics portfolio offering metabolite-level insight to connect molecular data with biological function across broader life science studies • New workflow built around Thermo Scientific Vanquish UHPLC coupled with Orbitrap Exploris 120 high-resolution accurate-mass mass ...

Pagination

  • First page «
  • Previous page ‹‹
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS